WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs. The drug from Merck was OK'd on Thursday for patients with artery-clogging cholesterol that persists even after taking statins, the standard medications for cutting heart [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 7 | 01-07-2026 |
| 2 | Health Canada Approves Zepbound for OSA in Adults With Obesity | 5 | 8 | 25-06-2026 |
| 3 | Пресс-конференция о первом российском препарате от коронавируса. Видеотрансляция | 0 | 0 | 01-06-2020 |
| 4 | Three-in-one pill cuts heart failure hospitalizations by 60% | 7 | 7 | 04-07-2026 |
| 5 | Минздрав одобрил первую и единственную в России таблетированную форму препарата для лечения СМА | 5 | 7 | 06-07-2026 |
| 6 | Medicare now covering some GLP-1s for $50. Here's what to know | 5 | 7 | 02-07-2026 |
| 7 | Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision | 0 | 5 | 22-06-2026 |
| 8 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 9 | ФАС: цена на препарат для терапии острого инфаркта миокарда снижена на 18% | 0 | 0 | 28-05-2025 |
| 10 | Нет мигрени и инсульту: российские ученные создали уникальное лекарство | 8 | 7 | 24-03-2026 |